Skip to content

Acupuncture based on specific acupoint theory for the reduction of atrial fibrillation burden: a randomized controlled pilot trial

Acupuncture based on specific acupoint theory for the reduction of atrial fibrillation burden: a randomized controlled pilot trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003095
Enrollment
Unknown
Registered
2020-03-07
Start date
2020-04-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Persistent AF lasting no more than 3 years; 2. Age between 18 and 75 years old (male or female); 3. No acupuncture treatment within the previous 6 months.

Exclusion criteria

Exclusion criteria: 1. Severe heart failure (New York Heart Association(NYHA)class III or IV); 2. Echocardiographic parameters: left ventricular ejection fraction 5.0cm; 3. Severe lung, liver, kidney disease or other serious primary diseases; 4. Skin allergy to ECG monitoring electrode patch. 5. The estimated life expectancy of < 1 year.

Design outcomes

Primary

MeasureTime frame
Atrial fibrillation burden at 6 months after catheter ablation;

Secondary

MeasureTime frame
Rate of repeat catheter ablation;Number of hospitalizations related to arrhythmia;Heart rate variability;Evaluation of the reliability and expectation of acupuncture therapy;Number of electrical cardioversion within 3 months after catheter ablation;Blind evaluation;AFEQT scale;Atrial fibrillation burden at 3 months after catheter ablation ;Recurrence of atrial fibrillation after catheter ablation;

Countries

China

Contacts

Public ContactCunzhi Liu

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

lcz623780@126.com+86 010-53912201

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026